Skip to main content
. 2021 Jan 28;11:2467. doi: 10.1038/s41598-021-82080-z

Table 4.

Factors associated with cutaneous allodynia in individuals with probable migraine in univariable and multivariable analyses.

Probable migraine Migraine
Univariable OR, 95% CI Multivariable OR, 95% CI Univariable OR, 95% CI Multivariable OR, 95% CI
Sex (Female) 1.4 (0.7–2.7) 1.4 (0.6–3.2) 1.3 (0.5–3.5) 1.0 (0.3–3.8)
Age (year)
20–29 REF REF REF REF
30–39 1.1 (0.4–3.5) 1.5 (0.4–5.6) 1.4 (0.3–6.4) 1.1 (0.2–5.9)
40–49 0.6 (0.2–1.7) 0.8 (0.2–2.9) 1.4 (0.3–6.8) 0.5 (0.1–3.3)
50–59 0.9 (0.3–2.5) 1.2 (0.3–2.9) 0.5 (0.07–3.4) 0.2 (0.2–1.7)
60–69 0.6 (0.2–2.0) 0.4 (0.1–2.3) 1.3 (0.3–7.8) 0.2 (0.1–4.9)
 > 70 1.3 (0.4–3.8) 1.4 (0.3–8.2) 0.0 (0.0–0.0)* 0.0 (0.0–0.0)*
Educational level
High school REF REF REF REF
Middle school or less 1.6 (0.6–4.2) 1.6 (0.4–6.3) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
College or more 1.3 (0.6–2.7) 0.9 (0.3–2.4) 0.9 (0.3–2.4) 0.4 (0.1–1.5)
Headache frequency per month
 < 1 REF REF REF REF
1–14 1.3 (0.7–2.5) 0.6 (0.2–1.3) 2.5 (0.9–7.3) 1.0 (0.3–3.8)
 ≥ 15 1.6 (0.2–15.4) 1.1 (0.1–11.9) 9.8 (1.6–59.9) 2.6 (0.4–18.6)
Headache intensity
Mild REF REF REF REF
Moderate 2.7 (1.3–5.8) 2.4 (1.1–5.4) 2.5 (1.6–4.0) 0.9 (0.2–4.6)
Severe 5.7 (1.9–16.8) 4.0 (1.1–13.9) 8.5 (4.4–16.1) 2.6 (0.4–18.6)
Anxiety (GAD-7 score ≥ 7) 9.0 (3.8–21.1) 5.2 (1.7–16.3) 11.3 (2.5–52.4) 11.6 (2.0–67.3)
Depression (PHQ-9 score ≥ 10) 5.7 (2.8–11.4) 3.3 (1.5–7.6) 2.8 (1.0–8.0) 1.1 (0.2–5.3)

OR: odds ratio, CI, confidence interval, GAD-7: Generalized Anxiety Disorder-7, PHQ-9: Patient Health Questionnaire-9. REF: Reference.

*No participant with migraine aged > 70 had cutaneous allodynia.

No participant with migraine had an educational level of middle school or less.

HHS Vulnerability Disclosure